Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cardiovascular Digital Solutions Market, by Service Type
1.4.2 North America Cardiovascular Digital Solutions Market, by End-use
1.4.3 North America Cardiovascular Digital Solutions Market, by Deployment
1.4.4 North America Cardiovascular Digital Solutions Market, by Components
1.4.5 North America Cardiovascular Digital Solutions Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Aug – 2022, Nov) Leading Players
Chapter 4. North America Cardiovascular Digital Solutions Market by Service Type
4.1 North America Unobtrusive Testing Market by Country
4.2 North America CVD Health Informatics Market by Country
4.3 North America Cardiac Rehab Programs Market by Country
4.4 North America Others Market by Country
Chapter 5. North America Cardiovascular Digital Solutions Market by End-use
5.1 North America Hospitals & Clinics Market by Country
5.2 North America Ambulatory Care Centers Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Cardiovascular Digital Solutions Market by Deployment
6.1 North America Cloud-Based Market by Country
6.2 North America On-premise Market by Country
Chapter 7. North America Cardiovascular Digital Solutions Market by Components
7.1 North America Devices Market by Country
7.2 North America Software Market by Country
Chapter 8. North America Cardiovascular Digital Solutions Market by Country
8.1 US Cardiovascular Digital Solutions Market
8.1.1 US Cardiovascular Digital Solutions Market by Service Type
8.1.2 US Cardiovascular Digital Solutions Market by End-use
8.1.3 US Cardiovascular Digital Solutions Market by Deployment
8.1.4 US Cardiovascular Digital Solutions Market by Components
8.2 Canada Cardiovascular Digital Solutions Market
8.2.1 Canada Cardiovascular Digital Solutions Market by Service Type
8.2.2 Canada Cardiovascular Digital Solutions Market by End-use
8.2.3 Canada Cardiovascular Digital Solutions Market by Deployment
8.2.4 Canada Cardiovascular Digital Solutions Market by Components
8.3 Mexico Cardiovascular Digital Solutions Market
8.3.1 Mexico Cardiovascular Digital Solutions Market by Service Type
8.3.2 Mexico Cardiovascular Digital Solutions Market by End-use
8.3.3 Mexico Cardiovascular Digital Solutions Market by Deployment
8.3.4 Mexico Cardiovascular Digital Solutions Market by Components
8.4 Rest of North America Cardiovascular Digital Solutions Market
8.4.1 Rest of North America Cardiovascular Digital Solutions Market by Service Type
8.4.2 Rest of North America Cardiovascular Digital Solutions Market by End-use
8.4.3 Rest of North America Cardiovascular Digital Solutions Market by Deployment
8.4.4 Rest of North America Cardiovascular Digital Solutions Market by Components
Chapter 9. Company Profiles
9.1 Apple, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 General Electric Company
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.3 Koninklijke Philips N.V.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Verily Life Sciences LLC (Alphabet, Inc.)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 iRhythm Technologies, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Research & Development Expense
9.6 Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.8 AliveCor, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Partnerships, Collaborations, and Agreements:
9.8.2.2 Product Launches and Product Expansions:
9.9 Cardiotrack
9.9.1 Company Overview
9.10. HeartFlow, Inc.
9.10.1 Company Overview
Unique Offerings 